Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
about
Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherenceManagement of the polyallergic patient with allergy immunotherapy: a practice-based approachSublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelinesRecommendations for appropriate sublingual immunotherapy clinical trialsPatients' compliance with different administration routes for allergen immunotherapy in Germany.Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial.Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center.Selection of patients for sublingual versus subcutaneous immunotherapy.The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy.Adherence to Sublingual Immunotherapy.Comprehensive Study of Patients' Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic Rhinitis.The impact of telemonitoring on adherence to nasal corticosteroid treatment in children with seasonal allergic rhinoconjunctivitis.Asthma with allergic rhinitis management in China: a nationwide survey of respiratory specialists at tertiary hospitals.[Adherence in specific immunotherapy].
P2860
Q26740381-E9491F25-462A-4AA6-969A-45B861362F72Q26772200-9EDA5C0B-C9A2-4232-8B99-8C1A7ECFFD28Q27002341-E47DB4F4-46FF-472D-9CD4-075B8D14F29EQ27011713-BC084CFE-BFD0-4BDA-B79B-4090620760EFQ34434850-2ABCEFC6-228C-499D-8502-AD1030155A3CQ35540640-1C260A9E-3A2F-4ACA-B93C-25F51714232FQ36113704-4C825706-5853-44EC-8484-BDA75A34C88AQ36529630-6E8DBEB6-6091-4345-8C34-BB17A8DAF4A2Q37573127-D8340CF3-F577-436E-B9C4-08CE2FFE3F1DQ38257644-9C703170-ADD3-4228-8C4C-4283D496C42EQ38278145-B1983E4B-92B9-4D38-BDAE-E342A48FFC4BQ38683390-7BCC6D21-4AB0-48E8-9B7A-3781495B40CEQ38693976-4F1BC5AC-2A60-4770-A51D-CA9F342A4A8DQ39676517-A261CFC9-1C72-435A-BA36-7533E8B77CF5Q51063847-B3D5D252-427B-41B1-91EF-12247A717289Q51683799-57865BD4-1A84-4F10-9A99-9FE0CA5AA030Q52718381-9C5C29B4-310E-4F82-B57B-2D27C57D5C28
P2860
Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
@en
type
label
Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
@en
prefLabel
Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
@en
P2860
P1476
Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis.
@en
P2093
P2860
P356
10.1111/J.1365-2222.2012.04052.X
P577
2013-01-01T00:00:00Z